CAPTRUST FINANCIAL ADVISORS - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$358,621
+348.3%
5,985
+563.5%
0.00%0.0%
Q2 2022$80,000
-20.0%
902
+1.1%
0.00%0.0%
Q1 2022$100,000
-51.7%
892
-33.3%
0.00%0.0%
Q4 2021$207,000
-1.4%
1,337
-11.4%
0.00%
-50.0%
Q3 2021$210,000
+8.8%
1,509
+2.4%
0.00%0.0%
Q2 2021$193,000
-14.2%
1,474
-0.1%
0.00%0.0%
Q1 2021$225,000
+1775.0%
1,475
+1150.0%
0.00%
Q4 2020$12,000
+9.1%
118
+4.4%
0.00%
Q3 2020$11,000
-83.1%
113
-80.6%
0.00%
-100.0%
Q2 2020$65,000
-41.4%
583
-64.3%
0.00%
-50.0%
Q1 2020$111,000
+200.0%
1,632
+338.7%
0.00%
+100.0%
Q3 2019$37,000
-11.9%
3720.0%0.00%
-50.0%
Q2 2019$42,0000.0%372
+12.0%
0.00%0.0%
Q1 2019$42,000
+281.8%
332
+300.0%
0.00%
+100.0%
Q4 2018$11,000
-52.2%
830.0%0.00%0.0%
Q3 2018$23,000
+2200.0%
83
+2666.7%
0.00%
Q2 2018$1,0000.0%3
-66.7%
0.00%
Q1 2018$1,00090.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
VILLERE ST DENIS J & CO LLC 518,988$80,162,0004.60%
Knott David M Jr 75,000$11,585,0003.93%
Orchard Capital Management, LLC 68,596$10,595,0003.11%
Chicago Capital, LLC 436,456$67,415,0002.51%
RICE HALL JAMES & ASSOCIATES, LLC 347,699$53,706,0001.91%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 85,990$13,282,0001.46%
Smith, Graham & Co., Investment Advisors, LP 87,392$13,499,0001.34%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 44,754$6,913,0001.12%
WOODSTOCK CORP 68,666$10,606,0001.11%
Stephens Investment Management Group LLC 411,359$63,539,0000.82%
View complete list of LIGAND PHARMACEUTICALS INC shareholders